SMTL ID : 6rz4.1

Crystal structure of cysteinyl leukotriene receptor 1 in complex with pranlukast

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x KNT: pranlukast(Non-covalent)

KNT.1: 21 residues within 4Å: Chain A: R.82, Y.107, Y.111, F.153, T.157, S.158, F.161, F.177, P.179, V.189, L.192, H.193, V.195, S.196, G.200, Y.361, R.365, H.368, L.369, L.372, L.393 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:Y.107, A:Y.111, A:F.153, A:P.179, A:L.192, A:V.195, A:L.372 Hydrogen bonds: A:R.82, A:Y.107, A:Y.107, A:R.365 Water bridges: A:R.82, A:R.82, A:Y.361 pi-Stacking: A:Y.111 pi-Cation interactions: A:R.365

1 x NA: SODIUM ION(Non-functional Binders)

NA.2: 5 residues within 4Å: Chain A: D.72, S.113, N.399, C.400, D.403 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:D.72, A:N.109, A:S.113

9 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)

OLC.3: 7 residues within 4Å: Chain A: P.360, I.363, Q.364, I.367, R.384, M.385, S.388 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:I.363, A:Q.364, A:I.367 Hydrogen bonds: A:R.384, A:S.388 OLC.4: 3 residues within 4Å: Chain A: I.126, F.130 Ligands: OLC.6 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:I.126 OLC.5: 8 residues within 4Å: Chain A: L.190, V.191, Y.194, V.195, F.198, V.199, I.203 Ligands: OLC.11 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:Y.194, A:F.198, A:V.199, A:I.203 OLC.6: 5 residues within 4Å: Chain A: F.122, C.125, V.210, C.211 Ligands: OLC.4 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:F.122 OLC.7: 7 residues within 4Å: Chain A: K.341, M.348, V.349, F.402, L.405, F.408, F.409 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.349, A:L.405, A:F.409, A:F.409, A:F.409 Hydrogen bonds: A:F.408 Salt bridges: A:K.341 OLC.8: 4 residues within 4Å: Chain A: T.31, S.34, M.35, V.39 No protein-ligand interaction detected (PLIP) OLC.9: 2 residues within 4Å: Chain A: T.157, V.195 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:T.157, A:V.195 OLC.10: 3 residues within 4Å: Chain A: F.122, F.123, V.146 No protein-ligand interaction detected (PLIP) OLC.11: 6 residues within 4Å: Chain A: V.146, G.149, I.150, F.153, V.199 Ligands: OLC.5 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:V.146, A:I.150, A:F.153, A:F.153, A:V.199

1 x OLA: OLEIC ACID(Non-covalent)

OLA.12: 5 residues within 4Å: Chain A: N.67, L.74, R.144, W.151, I.155 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.74, A:W.151, A:W.151, A:W.151, A:I.155 Hydrogen bonds: A:N.67 Salt bridges: A:R.144

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Luginina, A. et al., Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs. Sci Adv (2019)

Release Date

2019-10-30

Peptides

Cysteinyl leukotriene receptor 1,Soluble cytochrome b562,Cysteinyl leukotriene receptor 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Cysteinyl leukotriene receptor 1,Soluble cytochrome b562,Cysteinyl leukotriene receptor 1

Related Entries With Identical Sequence